| Can dynamic MR imaging predict response in patients with rectal cancer undergoing cetuximab-based neoadjuvant chemoradiation? | |
| | |
MedLine Citation:
|
PMID: 19295245 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: The aim of this study was to evaluate therapy response in patients undergoing cetuximab-CapIri-based chemoradiation for rectal cancer using dynamic magnetic resonance imaging (dMRI). PATIENTS AND METHODS: The volumetric degree of tumor regression and contrast media perfusion were compared to the results of the histopathologic ypTN staging. 33 patients were examined using a 1.5-T scanner with repetitive 2D FLASH sequences after contrast media application. All patients were examined twice - before therapy and immediately before surgery. RESULTS: In all patients, the tumor volume decreased (mean 72 +/- 16%). In 25/33 patients, the slope of the contrast media enhancement curve decreased (mean 31 +/- 20%). In histopathologically proven downstaging after therapy, the decrease in slope was significantly higher than in the group without downstaging, and the decrease in slope was better for distinguishing between 'responder' and 'non-responder' than the decrease in volume. CONCLUSION: Using dMRI helps to identify responders undergoing cetuximab-based chemoradiation better than volume decrease alone. |
| | |
Authors:
|
Dietmar J Dinter; Karoline Horisberger; Christian Zechmann; Frederik Wenz; Joachim Brade; Frank Willeke; K Wolfgang Neff; Stefan O Schoenberg; Ralf-Dieter Hofheinz |
Related Documents
:
|
2110925 - Schistosomal colonic disease. 16357385 - Automated insufflation of carbon dioxide for mdct colonography: distension and patient ... 2033355 - Left hemicolectomy with rectal excision for severe idiopathic constipation. 12095475 - Slow transit constipation. 9331205 - Eye injuries caused by bungee cords. 17874245 - Results of bilateral combined hip and knee arthroplasty in very young patients with juv... |
Publication Detail:
|
Type: Clinical Trial; Journal Article Date: 2009-02-13 |
Journal Detail:
|
Title: Onkologie Volume: 32 ISSN: 1423-0240 ISO Abbreviation: Onkologie Publication Date: 2009 Mar |
Date Detail:
|
Created Date: 2009-03-19 Completed Date: 2009-04-28 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7808556 Medline TA: Onkologie Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 86-93 Citation Subset: IM |
Copyright Information:
|
Copyright 2009 S. Karger AG, Basel. |
Affiliation:
|
Institut für Klinische Radiologie und Nuklearmedizin, Medizinische Fakultät Mannheim der Universität Heidelberg, Heidelberg, Germany. dietmar.dinter@medma.uni-heidelberg.de |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Aged Antibodies, Monoclonal / administration & dosage* Antineoplastic Agents / administration & dosage Female Humans Magnetic Resonance Imaging / methods* Male Middle Aged Prognosis Radiotherapy, Adjuvant / methods Radiotherapy, Conformal* Rectal Neoplasms / diagnosis*, therapy* Reproducibility of Results Sensitivity and Specificity Treatment Outcome |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/Antineoplastic Agents; 0/cetuximab |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Conduction failures in rabbit saphenous nerve unmyelinated fibers.
Next Document: Scarless endoscopic papillomectomy of the breast.